A carregar...
Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced Dyskinesias
Ketamine is an FDA-approved drug with a known safety profile. Low-dose subanesthetic intravenous ketamine infusion treatment has led to long-term reduction of treatment-resistant depression and of chronic pain states. We report on low-dose subanesthetic intravenous ketamine infusion treatment in Par...
Na minha lista:
| Publicado no: | Case Rep Neurol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4899651/ https://ncbi.nlm.nih.gov/pubmed/27293405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000444278 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|